Bank Of New York Mellon Corp Iveric Bio, Inc. Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$18.67 - $24.56 $10.2 Million - $13.5 Million	548,935 New	548,935 $13.4 Billion
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $9.99 Million - $13.9 Million	579,676 New	579,676 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $565,880 - $1.12 Million	60,200 Added 15.64%	445,157 $7.99 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $930,641 - $1.93 Million	-102,044 Reduced 20.95%	384,957 $3.7 Million
Q1 2022 May 11, 2022	BUY	$12.15 - $16.83 $442,102 - $612,393	36,387 Added 8.07%	487,001 $8.2 Million

Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $337,770 - $458,663	24,423 Added 5.73%	450,614 $7.53 Million
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $889,999 - $2.2 Million	125,884 Added 41.92%	426,191 $6.92 Million
Q2 2021 Aug 11, 2021	SELL	$5.69 - $7.17 $242,285 - $305,305	-42,581 Reduced 12.42%	300,307 $1.89 Million
Q1 2021 May 13, 2021	BUY	$5.08 - $6.89 $2,362 - $3,203	465 Added 0.14%	342,888 $2.12 Million
Q4 2020 Feb 09, 2021	BUY	$5.65 - $7.66 $507,047 - $687,431	89,743 Added 35.52%	342,423 $2.37 Million
Q3 2020 Nov 12, 2020	BUY	$4.01 - $6.29 $431,852 - $677,395	107,694 Added 74.28%	252,680 $1.43 Million
Q2 2020 Aug 12, 2020	BUY	$3.06 - $6.6 $377,426 - $814,057	123,342 Added 569.87%	144,986 $739,000
Q4 2019 Feb 14, 2020	SELL	$0.93 - $8.58 $632 - $5,834	-680 Reduced 3.05%	21,644 $185,000
Q2 2019 Aug 12, 2019	BUY	$1.21 - $1.48 $27,012 - $33,039	22,324 New	22,324 $29,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.